A new coding mutation in the Tnf-α leader sequence in tuberculosis-sensitive I/St mice causes higher secretion levels of soluble TNF-α
Open Access
- 14 July 2005
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 6 (7) , 620-627
- https://doi.org/10.1038/sj.gene.6364249
Abstract
I/St and A/Sn mice are polar extremes in terms of several parameters defining sensitivity to Mycobacterium tuberculosis. TNF-α, mainly produced by activated macrophages, can mediate both physiological and pathophysiological processes. Adequate TNF-α levels are essential for a forceful protective response to M. tuberculosis. We have functionally characterized a nonsynonymous substitution, Arg8His, in the highly conserved cytoplasmic domain of the pro-TNF-α leader peptide from extremely M. tuberculosis-sensitive I/St mice. This was compared to the common pro-TNF-α variant found in A/Sn mice. Using cDNA constructs, both variants were constitutively expressed in HEK293A cells. A significantly higher secretion level of Arg8His TNF-α was shown using flow cytometry and ELISA analysis (P=0.0063), while intracellular levels were similar for both protein variants. An even TNF-α distribution throughout the cells was seen using confocal microscopy. This suggests that the Arg8His substitution affects pro-TNF-α processing. The I/St mouse may serve as a model to further explore the function of the well-conserved cytoplasmic region of TNF-α. However, other identified substitutions in the I/St promoter, introns and 3′UTR of Tnf-α, as well as the cellular environment in vivo may affect the balance between soluble and intracellular Arg8His TNF-α before and during M. tuberculosis infection.Keywords
This publication has 46 references indexed in Scilit:
- What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells?Microbes and Infection, 2004
- Different Innate Ability of I/St and A/Sn Mice To Combat VirulentMycobacterium tuberculosis: Phenotypes Expressed in Lung and Extrapulmonary MacrophagesInfection and Immunity, 2003
- Multigenic Control of Disease Severity after VirulentMycobacterium tuberculosisInfection in MiceInfection and Immunity, 2003
- Influence of TNFα gene polymorphisms on TNFα production and diseaseHuman Immunology, 2001
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting EnzymeJournal of Biological Chemistry, 2000
- Noncleavable Transmembrane Mouse Tumor Necrosis Factor-α (TNFα) Mediates Effects Distinct from Those of Wild-type TNFα in Vitro and in VivoJournal of Biological Chemistry, 1999
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contactCell, 1990